Ginkgo Bioworks (DNA) Q1 Revenues Beat; Guides Higher
Get Alerts DNA Hot Sheet
Join SI Premium – FREE
Ginkgo Bioworks (NYSE: DNA) reported Q1 revenue $168 million versus the consensus estimate of $105.68 million.
GUIDANCE:
Ginkgo Bioworks sees FY2022 revenue of $375-390 million, versus the consensus of $333 million.
For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- O'Reilly Automotive (ORLY) Misses Q1 EPS by 7c, Offers Guidance
- Plexus Corp (PLXS) Tops Q2 EPS by 7c
- ChampionX (CHX) Tops Q1 EPS by 8c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!